LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on Latin America, announced that its mobile healthcare application has entered its final development stage. The company is completing testing, optimization, and deployment preparation, with plans to submit the app to the Apple App Store and Google Play in the coming weeks, subject to platform approval.
This milestone transitions LataMed AI from application development to public availability, providing a primary mobile access point to its digital healthcare ecosystem. The app aims to offer users a convenient interface for supported healthcare services, digital tools, and future functionality. The company's development team is focused on final technical testing, interface optimization, and platform compatibility.
Once launched, the app is expected to serve as a scalable mobile foundation for introducing additional healthcare features, including patient-facing tools, provider interaction, digital communications, and healthcare-service coordination. LataMed AI emphasizes that mobile accessibility is crucial in Latin America, where smartphones are a primary means of accessing digital services for many individuals.
The application aligns with the company's broader strategy to connect patients, healthcare professionals, pharmacies, insurers, payment providers, and wellness organizations in an integrated digital healthcare environment. LataMed AI continues to develop its AI-supported technologies, including CardioAI, PulmoAI, and NeuroAI, with the mobile infrastructure intended to provide an additional pathway for user interaction.
“Our mobile application is now moving from development toward deployment, and we believe we are approaching an important milestone for LataMed AI,” said Dr. Kevin Rodan Levy, CEO. “Our team is completing the final stages of testing and preparation, and we currently expect the application to become available through the Apple App Store and Google Play in the coming weeks, subject to the applicable platform review processes.”
Dr. Levy added, “Mobile availability is important because it provides a direct connection between users and the digital healthcare ecosystem we are building. Our objective is to create a platform that is practical, accessible, and capable of expanding as we continue introducing additional healthcare services and artificial intelligence-supported tools.”
The anticipated release represents another step in moving LataMed AI's technology into user-facing infrastructure. Following the initial launch, the company plans to evaluate additional functionality and platform integrations for future versions. Further updates will be provided as milestones are completed.
For more information, visit https://latamed.ai or review the company's SEC filings at www.sec.gov.
